Paramita Therapeutics is a biotech company that focuses on developing new cancer and infectious disease therapeutics.
Paramita Therapeutics has raised $353K in total funding. The most recent round was Grant. The last funding was announced in November 2025.
Paramita Therapeutics's investors include National Science Foundation, National Cancer Institute.
Paramita Therapeutics is headquartered in San Diego, United States.
Paramita Therapeutics is a biotech company that focuses on developing new cancer and infectious disease therapeutics.
Paramita Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Paramita Therapeutics — Funding & Investors." VCBacked, November 19, 2025, https://www.vcbacked.co/company/paramita-therapeutics. Accessed August 13, 2026.
VCBacked. (2025). Paramita Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/paramita-therapeutics
{{cite web |title=Paramita Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/paramita-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated